Paula Opal, RAC
Ms. Opal joined Connect in July 2021 and has more than 20 years of experience in US and Global regulatory affairs across a variety of therapeutic areas including infectious disease, neurology, and immunology. She has led Global and Regional teams managing regulatory projects for small and large molecules from Pre‑IND through Post Approval studies including pivotal studies leading to successful NDA/BLA submissions resulting in approvals. Prior to joining Connect, Ms. Opal worked in senior regulatory positions at Rezolute and Genentech-Roche; earlier in her career she supported key regulatory filings at Gilead Sciences and OSI Pharmaceuticals. She received her Bachelor’s degree from the University of Colorado at Boulder and holds a RAC certification.